Make one change at a time and maintain a straightforward symptom log
In this guide, well break down what we know (and what we dont) about BPC-157s half-life, how long it stays in your body, and how this impacts its safe and effective use
HUBERMAN: While I'm not opposed to that approach, you just want to make sure that the dosing, or I should say the relative dosing of each peptide is such that, you know, You're avoiding unnecessary increases in prolactin and cortisol, and that you're not hitting a pathway redundantly
Back in June I was tested for B12 due to extreme
[ 12 , 16 ] Researchers hypothesize that this mechanism could contribute to some of the sleep-related effects reported in early studies
The Regulatory Reality of 2026: What Actually Changed In late 2023, the FDA moved 19 peptides, including BPC-157, to what's known as "Category 2" status under its framework for bulk drug substances used in compounding, identifying them as substances that "may present significant safety risks." The concern, as stated in FDA guidance, centered on the limited large-scale human data and questions about immunogenicity